ZimVie Inc. (ZIMV)

US — Healthcare Sector
Peers: SYK  BSX  STE  SNN  NUVA  CNMD  KIDS  LUNG  SIBN  NPCE  CVRX  OFIX  AORT  HSKA  SGHT  INGN  SRDX  APYX 

Automate Your Wheel Strategy on ZIMV

With Tiblio's Option Bot, you can configure your own wheel strategy including ZIMV - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol ZIMV
  • Rev/Share 16.0707
  • Book/Share 14.3161
  • PB 0.6384
  • Debt/Equity 0.5889
  • CurrentRatio 2.1397
  • ROIC -0.0194

 

  • MktCap 255202958.0
  • FreeCF/Share 0.2624
  • PFCF 35.2344
  • PE -17.5965
  • Debt/Assets 0.312
  • DivYield 0
  • ROE -0.0363

 

  • Rating C-
  • Score 1
  • Recommendation Strong Sell
  • P/E Score 1
  • DCF Score 1
  • P/B Score 4
  • D/E Score 1

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
Initiation ZIMV B. Riley Securities -- Buy -- $16 April 10, 2025
Downgrade ZIMV Needham Buy Hold -- -- March 13, 2025

News

ZimVie Pioneers the Future of Molar Restoration with New Immediate Molar Dental Implant System
ZIMV
Published: April 21, 2025 by: GlobeNewsWire
Sentiment: Neutral

PALM BEACH GARDENS, Fla., April 21, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental implant market, today announced the launch of its Immediate Molar Implant System in the United States.

Read More
image for news ZimVie Pioneers the Future of Molar Restoration with New Immediate Molar Dental Implant System
Dental Players Dentsply Sirona, ZimVie Show Weak Growth Outlook: Analyst
XRAY, ZIMV
Published: March 13, 2025 by: Benzinga
Sentiment: Negative

Dentsply Sirona XRAY and ZimVie Inc. ZIMV show below-market growth and have no meaningful upside, according Needham analysts.

Read More
image for news Dental Players Dentsply Sirona, ZimVie Show Weak Growth Outlook: Analyst
ZimVie Inc. (ZIMV) Q4 2024 Earnings Call Transcript
ZIMV
Published: February 26, 2025 by: Seeking Alpha
Sentiment: Neutral

ZimVie Inc. (NASDAQ:ZIMV ) Q4 2024 Earnings Conference Call February 26, 2025 4:30 PM ET Company Participants Marissa Bych - Investor Relations Vafa Jamali - President & Chief Executive Officer Richard Heppenstall - Chief Financial Officer Conference Call Participants David Saxon - Needham & Company Kevin Caliendo - UBS William McMahon - Barclays Operator Good afternoon and welcome to ZimVie's Fourth Quarter 2024 Earnings Conference Call. Currently, all participants are in a listen-only mode.

Read More
image for news ZimVie Inc. (ZIMV) Q4 2024 Earnings Call Transcript

About ZimVie Inc. (ZIMV)

  • IPO Date 2022-02-16
  • Website https://www.zimvie.com
  • Industry Medical - Devices
  • CEO Mr. Vafa Jamali
  • Employees 1770

ZimVie Inc., a medical technology company, develops, manufactures, and delivers a portfolio of products and solutions designed to treat a range of spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; bone grafts, barrier membranes, allografts, and collagen wound care products; intraoral scanners; and virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and patient-specific restorative components and intra-oral scanners, as well as spinal fusion implants and instrumentation for various spinal procedures, biologics, and bone healing technologies. The company also provides MIS solutions, such as Vital MIS and Timberline; and motion preservation solutions, including Mobi-C and The Tether. ZimVie Inc. was incorporated in 2021 and is headquartered in Westminster, Colorado.